Methyl-group donor supplementation beneficial effects on metabolic, histological, and inflammatory parameters in a murine model of alcoholic steatohepatitis

Methyl-group donor supplementation beneficial effects on metabolic, histological, and inflammatory parameters in a murine model of alcoholic steatohepatitis

Introduction and Objectives: Chronic alcohol consumption is the main cause of alcohol-related liver disease (ARLD) ranging a spectrum characterized by inflammation and progressive fibrosis. Currently, abstinence is the main treatment for ARLD; for this reason, it becomes indispensable to evaluate th...

Full description

Bibliographic Details
Main Authors:	Carolina Diaz-Canul, Angel O. Vázquez-Esqueda, Rebeca Rosas-Campos, Marina Galicia-Moreno, Armendariz-Borunda Juan, Ana Sandoval-Rodriguez
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S166526812400262X

Similar Items

Effect of methyl donor supplementation on gut microbiota and hepatic expression of key miRNAs in a murine model of MAFLD
by: Rebeca Rosas-Campos, et al.
Published: (2024-02-01)

Dietary supplementation with methyl donors improves physiopathological conditions of NAFLD in a murine model
by: A Vazquez Esqueda, et al.
Published: (2022-12-01)

P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS
by: Carolina Díaz Canul, et al.
Published: (2024-12-01)

Exploring the metabolic and molecular benefits of methyl donor supplementation in a model of metabolic and fatty liver disease
by: Angel Vazquez-Esqueda, et al.
Published: (2024-02-01)

N-acetyl cysteine prevents alterations generated during experimental liver steatosis induced by a chronic consumption of alcohol plus a hypercaloric diet.
by: Marina Galicia-Moreno, et al.
Published: (2024-02-01)

Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel
by: Daniel López-Cifuentes, et al.
Published: (2024-02-01)

P- 25 ANTIOXIDANT EFFECT OF MORINGA OLEIFERA IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS
by: Alejandra Monraz-Méndez, et al.
Published: (2023-03-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

MexMix supplementation prevented MAFLD development by restoring microbiota-gut-liver axis in a mice model.
by: Rebeca Rosas-Campos, et al.
Published: (2024-02-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-03-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-05-01)

Mexican Ancestral Foods (<i>Theobroma cacao, Opuntia ficus indica, Persea americana</i> and <i>Phaseolus vulgaris)</i> Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis
by: Rebeca Escutia-Gutiérrez, et al.
Published: (2023-03-01)

A Simple Algorithm for Semiquantitative Analysis of Scored Histology Data in the R Environment, on the Example of Murine Non-Alcoholic Steatohepatitis Pharmacotherapy
by: Veronika A. Prikhodko, et al.
Published: (2022-12-01)

Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
by: Naomichi Abe, et al.
Published: (2019-05-01)

Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?
by: Nae-Yun Heo
Published: (2016-05-01)

Molecular, histological and biochemical changes in a NASH murine model whit a diet high in fats and sugars
by: J.S. Rodríguez Sanabria, et al.
Published: (2020-09-01)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
by: Sachiko Hattori, et al.
Published: (2021-03-01)

Prolonged-release pirfenidone prevents myocardial fibrosis in a mouse nonalcoholic steatohepatitis model
by: J. Gutiérrez-Cuevas, et al.
Published: (2020-09-01)

The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis
by: Farid Kosari, et al.
Published: (2019-01-01)

Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
by: Rudolf E. Stauber, et al.
Published: (2024-05-01)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
by: J. Samael Rodríguez-Sanabria, et al.
Published: (2022-01-01)

IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.
by: Emmanuel Mas, et al.
Published: (2009-11-01)

Association of weight changes with changes in histological features and blood markers in non-alcoholic steatohepatitis
by: Koutoukidis, D, et al.
Published: (2021)

Experimental murine non-alcoholic steatohepatitis is associated with behavioural, cognitive, and peripheral neuronal dysfunction
by: V. A. Prikhodko, et al.
Published: (2023-09-01)

Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
by: Charles H. Halsted, et al.
Published: (2012-01-01)

Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life
by: Heath, L, et al.
Published: (2022)

Ethyl alcohol supplement not beneficial to cattle in feedlot tests
by: W Garrett, et al.
Published: (1963-09-01)

Glycyrrhizinic Acid and Phosphatidylcholine Combination as a Preventive Therapy for Experimental Murine Non-Alcoholic Steatohepatitis
by: Veronika A. Prikhodko, et al.
Published: (2024-01-01)

Dietary supplementation with Mexican foods, Opuntia ficus indica, Theobroma cacao, and Acheta domesticus: Improving obesogenic and microbiota features in obese mice
by: Rebeca Rosas-Campos, et al.
Published: (2022-12-01)

Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans.
by: Michiko Itoh, et al.
Published: (2013-01-01)

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
by: Emma Hymel, et al.
Published: (2022-12-01)

Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)

Endocannabinoids and non-alcoholic steatohepatitis
by: Helmy Ahmed
Published: (2006-01-01)

Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021-11-01)

Fructose and Non-Alcoholic Steatohepatitis
by: Elke Roeb, et al.
Published: (2021-02-01)

Role of alcohol metabolism in non-alcoholic steatohepatitis.
by: Susan S Baker, et al.
Published: (2010-03-01)

IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models.
by: Jose E Heredia, et al.
Published: (2022-01-01)

IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models
by: Jose E. Heredia, et al.
Published: (2022-01-01)

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
by: Feng Liu, et al.
Published: (2022-06-01)

Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
by: Shahinul Alam, et al.
Published: (2016-01-01)